Question Bank › Insider capital committed alongside shareholders

Insider capital committed alongside shareholders

Calls Tested
498
Answered YES
25
Hit Rate
5%
rare by design

Zscaler, Inc. (ZS) — this company's answers

NO on the Q3 2018 call 2018-06-06 B+

← Back to the full ZS analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management describe an action that ties insiders' or the company's OWN capital more tightly to the per-share outcome, in a way that costs them something now? Answer YES if, in management's own words anywhere on the call (prepared remarks or Q&A), at least one of the following is affirmatively described as done, in progress, or newly committed: (a) an executive, director, founder, or the management team personally bought company stock with their own money, increased their personal stake, or declined/deferred/converted cash compensation into equity, or a named insider agreed to extended lock-up or holding requirements; (b) the company repurchased shares — or newly authorized/expanded a repurchase — and management explicitly frames it as buying because the shares are undervalued relative to the intrinsic or asset value management sees, rather than as offsetting dilution, returning excess cash, hitting a payout ratio, or a routine ongoing program; (c) management states it is retiring/reducing debt, redeeming preferred, or unwinding a dilutive instrument (warrants, converts, earn-out shares) specifically to reduce future share count or fixed claims ahead of schedule, using cash it could otherwise have kept; or (d) management explicitly redesigned incentive compensation so that payouts now depend on a specific long-horizon per-share or capital-return metric (e.g., return on invested capital, free cash flow per share, multi-year total shareholder return) and says this took effect or was just approved. The action must be a concrete, already-taken or newly committed step described by management, with enough specificity to identify who acted and what was committed. Answer NO if the discussion is only a generic mention of a buyback, dividend, or capital-allocation "priority" without the undervaluation rationale in (b); NO if it is only a plan, possibility, or something management "w Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
CNXC Concentrix Corporation Q2 2025 2025-06-26 B+
CHRRF Chorus Aviation Inc. Q1 2025 2025-05-09 B+
SLND Southland Holdings, Inc. Q4 2024 2025-03-05 D
HEAR Turtle Beach Corporation Q2 2024 2024-08-10 A
MNKD MannKind Corporation Q4 2023 2024-02-27 C
PUMP ProPetro Holding Corp. Q4 2023 2024-02-21 C+
CFRHF Compagnie Financière Richemont SA Q2 2024 2023-11-12 C+
KRRGF Karora Resources Inc. Q3 2023 2023-11-10 B+
PFIE Profire Energy, Inc. Q1 2023 2023-05-13 B
CTHR Charles & Colvard, Ltd. Q1 2023 2022-11-06 F
WD Walker & Dunlop, Inc. Q2 2022 2022-08-09 C+
CIVB Civista Bancshares, Inc. Q2 2022 2022-07-31 B
ZEPP Zepp Health Corporation Q1 2022 2022-05-24 D
SEED Origin Agritech Limited Q2 2022 2022-05-08 D
KPELA Keppel Corporation Limited's Q4 2021 2022-01-27 B+
TJX The TJX Companies, Inc. Q2 2021 2021-08-18 C
LOPE Grand Canyon Education, Inc. Q2 2021 2021-08-08 C
ESRT Empire State Realty Trust, Inc. Q2 2021 2021-07-29 C+
MOFG MidWestOne Financial Group, Inc. Q2 2021 2021-07-23 B
KIM Kimco Realty Corporation Q2 2018 2018-07-26 B+
GNTX Gentex Corporation Q3 2017 2017-10-20 B
TPB Turning Point Brands, Inc. Q1 2017 2017-05-11 B
WNS WNS Holdings' Q3 2017 2017-01-19 B+
HPP Hudson Pacific Properties, Inc. Q4 2015 2016-02-25 C
GNC GNC Holdings Q4 2015 2016-02-11 C+

More from the question bank

Self-blame with named internal fixNewly won customer expanding beyond initial Competitor stumble named, demand inboundCustomers locking in longer commitmentsCapacity sold out ahead of buildMilestone beaten early and bar raisedAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.